Seda Arat

Groton, Connecticut, United States Contact Info
1K followers 500+ connections

Join to view profile

About

• Accomplished data scientist with 12+ years of experience in leading and managing…

Experience & Education

  • Pfizer

View Seda’s full experience

See their title, tenure and more.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Licenses & Certifications

  • Data/Software Carpentry Instructor Training

    Software Carpentry

    Issued
  • Regression Models Graphic

    Regression Models

    Coursera

    Issued
  • Mathematical Biostatistics Boot Camp 2 Graphic

    Mathematical Biostatistics Boot Camp 2

    Coursera

    Issued
  • Mathematical Biostatistics Boot Camp 1 Graphic

    Mathematical Biostatistics Boot Camp 1

    Coursera

    Issued
  • Introduction to Data Science Graphic

    Introduction to Data Science

    Coursera

    Issued

Volunteer Experience

  • National Postdoctoral Association Graphic

    Volunteer

    National Postdoctoral Association

    - 1 year 1 month

    Science and Technology

  • The Jackson Laboratory Graphic

    Webmaster, UConn Health & Jackson Lab Postdoc Association (UJPDA)

    The Jackson Laboratory

    - 1 year 3 months

    Science and Technology

  • The Jackson Laboratory Graphic

    Co-chair, The Jackson Laboratory Postdoctoral Association (JPA)

    The Jackson Laboratory

    - 10 months

    Education

  • ISCB - International Society for Computational Biology Graphic

    Volunteer at the ISMB2016

    ISCB - International Society for Computational Biology

    - Present 8 years 1 month

    Science and Technology

    The annual international conference on Intelligent Systems for Molecular Biology (ISMB) is the major meeting of the International Society for Computational Biology (ISCB). Over the past 23 years the ISMB conference has grown to become the world's largest bioinformatics/computational biology conference. ISMB 2016 will be the year's most important computational biology event globally.

    The conferences provide a multidisciplinary forum for disseminating the latest developments in…

    The annual international conference on Intelligent Systems for Molecular Biology (ISMB) is the major meeting of the International Society for Computational Biology (ISCB). Over the past 23 years the ISMB conference has grown to become the world's largest bioinformatics/computational biology conference. ISMB 2016 will be the year's most important computational biology event globally.

    The conferences provide a multidisciplinary forum for disseminating the latest developments in bioinformatics/computational biology. ISMB brings together scientists from computer science, molecular biology, mathematics, statistics and related fields. Its principal focus is on the development and application of advanced computational methods for biological problems. ISMB 2016 offers the strongest scientific program and the broadest scope of any international bioinformatics/computational biology conference. Building on past successes, the conference is designed to cater to variety of disciplines within the bioinformatics/computational biology community.

  • UConn Health Graphic

    Co-organizer of Algebraic and Combinatorial Approaches in Systems Biology 2015 (ACSB2015)

    UConn Health

    - 11 months

    Education

    - Webmaster for the conference website
    - A part of the selection team for the presentation abstracts
    - A part of the decision team for the conference program

  • Abstract reviewer

    Society for Advancement of Chicanos and Native Americans in Science (SACNAS)

    - Present 11 years

    Science and Technology

  • Biocomplexity Institute of Virginia Tech Graphic

    Volunteer

    Biocomplexity Institute of Virginia Tech

    - Present 12 years 9 months

    Science and Technology

    Researchers led by Stephen Eubank, Ph.D., at Virginia Bioinformatics Institute (VBI) engaged visitors in simulating the spread of a contagious outbreak of Hokie Fever during the university Open House event on Saturday, November 12, 2011. Virginia Tech's famous head coach Frank Beamer will act as the source point for Hokie Fever.

  • Volunteer

    Kids' Tech University at Virginia Bioinformatics Institute

    - 1 year 4 months

    Children

    Kids' Tech University (KTU) is a pioneering educational initiative designed to excite children about science and provide them with a real university experience. Kids' Tech University was spearheaded by VBI in collaboration with the Virginia Cooperative Extension’s 4-H Youth Development Program. K-12 students, their parents and teachers, come to the Virginia Tech campus and they participate in a series of engaging scientific activities, including lectures by world-renown researchers and hands-on…

    Kids' Tech University (KTU) is a pioneering educational initiative designed to excite children about science and provide them with a real university experience. Kids' Tech University was spearheaded by VBI in collaboration with the Virginia Cooperative Extension’s 4-H Youth Development Program. K-12 students, their parents and teachers, come to the Virginia Tech campus and they participate in a series of engaging scientific activities, including lectures by world-renown researchers and hands-on laboratory experiments. The goal is to expose K-12 students early to cutting-edge research in science, math, engineering, and technology to hopefully encourage them to pursue science careers.

Publications

  • Use of the dTAG system in vivo to degrade CDK2 and CDK5 in adult mice and explore potential safety liabilities

    Toxicological Sciences

    The degradation tag (dTAG) system for target protein degradation can remove proteins from biological systems without the drawbacks of some genetic methods, such as slow kinetics, lack of reversibility, low specificity, and the inability to titrate dosage. These drawbacks can make it difficult to compare toxicity resulting from genetic and pharmacological interventions, especially in vivo. Because the dTAG system has not been studied extensively in vivo, we explored the use of this system to…

    The degradation tag (dTAG) system for target protein degradation can remove proteins from biological systems without the drawbacks of some genetic methods, such as slow kinetics, lack of reversibility, low specificity, and the inability to titrate dosage. These drawbacks can make it difficult to compare toxicity resulting from genetic and pharmacological interventions, especially in vivo. Because the dTAG system has not been studied extensively in vivo, we explored the use of this system to study the physiological sequalae resulting from CDK2 or CDK5 degradation in adult mice. Mice with homozygous knock-in of the dTAG sequence onto CDK2 and CDK5 were born at Mendelian ratios despite decreased CDK2 or CDK5 protein levels in comparison with wild-type mice. In bone marrow cells and duodenum organoids derived from these mice, treatment with the dTAG degrader dTAG-13 resulted in rapid and robust protein degradation but caused no appreciable change in viability or the transcriptome. Repeated delivery of dTAG-13 in vivo for toxicity studies proved challenging; we explored multiple formulations in an effort to maximize degradation while minimizing formulation-related toxicity. Degradation of CDK2 or CDK5 in all organs except the brain, where dTAG-13 likely did not cross the blood brain barrier, only caused microscopic changes in the testis of CDK2dTAG mice. These findings were corroborated with conditional CDK2 knockout in adult mice. Our results suggest that the dTAG system can provide robust protein degradation in vivo and that loss of CDK2 or CDK5 in adult mice causes no previously unknown phenotypes.

    Other authors
    See publication
  • Effects of Donor Source on Transcriptomic Profiles of Human Kidney Tissue

    FASEB

    Normal human tissue is a critical reference control in biomedical research. However, the type of tissue donor can significantly affect the underlying biology of the samples. We investigated the impact of tissue donor source type by performing transcriptomic analysis on healthy kidney tissue from three donor source types: cadavers, organ donors, and normal-adjacent tissue from surgical resections of clear cell renal cell carcinomas, and we compared the gene expression profiles to those of clear…

    Normal human tissue is a critical reference control in biomedical research. However, the type of tissue donor can significantly affect the underlying biology of the samples. We investigated the impact of tissue donor source type by performing transcriptomic analysis on healthy kidney tissue from three donor source types: cadavers, organ donors, and normal-adjacent tissue from surgical resections of clear cell renal cell carcinomas, and we compared the gene expression profiles to those of clear cell renal cell carcinoma samples. Comparisons among the normal samples revealed general similarity, with notable differences in gene expression pathways involving immune system and inflammatory processes, response to extracellular stimuli, ion transport, and metabolism. When compared to tumors, the transcriptomic profiles of the normal adjacent tissue were highly similar to the profiles from cadaveric and organ donor tissue samples, arguing against the presence of a field cancerization effect in clear cell renal cell carcinoma. We conclude that all three normal source types are suitable for reference kidney control samples, but important differences must be noted for particular research areas and tissue banking strategies.

    Other authors
    See publication
  • Nonclinical safety signals in PharmaPendium improve the predictability of human drug-induced liver injury

    Chemical Research in Toxicology

    Drug-induced liver injury (DILI) is a leading cause of candidate attrition during drug development in the pharmaceutical industry. This study evaluated liver toxicity signals for 249 approved drugs (114 of “most-DILI concern” and 135 of “no-DILI concern”) using PharmaPendium and assessed the association between nonclinical and clinical injuries using contingency tables. All animal liver findings were combined into eight toxicity categories based on nature and severity. Together, these analyses…

    Drug-induced liver injury (DILI) is a leading cause of candidate attrition during drug development in the pharmaceutical industry. This study evaluated liver toxicity signals for 249 approved drugs (114 of “most-DILI concern” and 135 of “no-DILI concern”) using PharmaPendium and assessed the association between nonclinical and clinical injuries using contingency tables. All animal liver findings were combined into eight toxicity categories based on nature and severity. Together, these analyses revealed that cholestasis [odds ratio (OR): 5.02; 95% confidence interval (CI) 1.04–24.03] or liver aminotransferase (AST) increases (OR: 1.86; 95% CI 1.09–3.09) in rats and steatosis (OR-1.9; 95% CI 1.03–3.49) or liver AST increases (OR-2.57; 95% CI 1.4–4.7) in dogs were significant predictors of human liver injury. The predictive value further improved when the liver injury categories were combined into less severe (steatosis, cholestasis, liver AST increase, hyperbilirubinemia, or jaundice) and more-severe (liver necrosis, acute liver failure, or hepatotoxicity) injuries. In particular, less-severe liver injuries in the following pairs of species predicted human hepatotoxicity {[dog & mouse] (OR: 2.70; 95% CI 1.25–5.84), [dog & rat] (OR-2.61; 95% CI 1.48–4.59), [monkey & mouse] (OR-4.22; 95% CI 1.33–13.32), and [monkey & rat] (OR-2.45; 95% CI 1.15–5.21)} were predictive of human hepatotoxicity. Meanwhile, severe liver injuries in both [dog & rat] (OR-1.9; 95% CI 1.04–3.49) were significant predictors of human liver toxicity. We concluded that the occurrence of DILI in humans is highly likely if liver injuries are observed in one rodent and one nonrodent species and that liver AST increases in dogs and rats can predict DILI in humans. Together, these findings indicate that the liver safety signals observed in animal toxicity studies indicate potential DILI risk in humans and could be used to prioritize small molecules with less potential to cause DILI in humans.

    Other authors
    See publication
  • Pfizer's Green Chemistry Program: 20 Years of Scientific Breakthroughs That Both Change Patients’ Lives and Sustain a Healthy Planet

    ACS Green Chemistry Institute

    One definition for Green Chemistry (GC) is the design of chemical products and processes that reduce or eliminate the use or generation of hazardous substances. Pfizer has embraced this concept and applied it across the life cycle of its products, facilitating process design, manufacturing, and utilization. Green chemistry principles provide a unique framework to guide process development, which ultimately leads to an optimal chemical process from both an environmental and economic perspective.

    See publication
  • T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model

    Journal of Hepatology

    Background & Aims
    Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs) which are more severe when ICIs are used in combination. We aimed to use a mouse model to elucidate the molecular mechanisms of immune-related hepatitis, one of the common irAEs associated with ICIs.

    Methods
    Immune phenotyping and molecular profiling were performed on Pdcd1-/- mice treated with anti-CTLA4 and/or the IDO1 inhibitor epacadostat or a 4-1BB agonistic…

    Background & Aims
    Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs) which are more severe when ICIs are used in combination. We aimed to use a mouse model to elucidate the molecular mechanisms of immune-related hepatitis, one of the common irAEs associated with ICIs.

    Methods
    Immune phenotyping and molecular profiling were performed on Pdcd1-/- mice treated with anti-CTLA4 and/or the IDO1 inhibitor epacadostat or a 4-1BB agonistic antibody.

    Results
    ICI combination-induced hepatitis and 4-1BB agonist-mediated hepatitis share similar features yet maintain distinct immune signatures. Both were characterized by an expansion of periportal infiltrates and pan-zonal inflammation albeit with different morphologic characteristics. In both cases, infiltrates were predominantly CD4+ and CD8+ T cells with upregulated T-cell activation markers, ICOS and CD44. Depletion of CD8+ T cells abolished ICI-mediated hepatitis. Single-cell transcriptomics revealed that the hepatitis induced by combination ICIs is associated with a robust immune activation signature in all subtypes of T cells and T helper 1 skewing. Expression profiling revealed a central role for IFNγ and liver monocyte-derived macrophages in promoting a pro-inflammatory T-cell response to ICI combination and 4-1BB agonism.

    Conclusion
    We developed a novel mouse model which offers significant value in yielding deeper mechanistic insight into immune-mediated liver toxicity associated with various immunotherapies.

    Lay summary
    Hepatitis is one of the common immune-related adverse events in cancer patients receiving immune checkpoint inhibitor (ICI) therapy. The mechanisms of ICI-induced hepatitis are not well understood. In this paper, we identify key molecular mechanisms mediating immune intracellular crosstalk between liver T cells and macrophages in response to ICI in a mouse model.

    See publication
  • Evaluating the sensitivity and specificity of promising circulating biomarkers to diagnose liver injury in humans

    Toxicological Sciences

    Early diagnosis of drug-induced liver injury (DILI) continues to be a major hurdle during drug development and postmarketing. The objective of this study was to evaluate the diagnostic performance of promising biomarkers of liver injury—glutamate dehydrogenase (GLDH), cytokeratin-18 (K18), caspase-cleaved K18 (ccK18), osteopontin (OPN), macrophage colony-stimulating factor (MCSF), MCSF receptor (MCSFR), and microRNA-122 (miR-122) in comparison to the traditional biomarker alanine…

    Early diagnosis of drug-induced liver injury (DILI) continues to be a major hurdle during drug development and postmarketing. The objective of this study was to evaluate the diagnostic performance of promising biomarkers of liver injury—glutamate dehydrogenase (GLDH), cytokeratin-18 (K18), caspase-cleaved K18 (ccK18), osteopontin (OPN), macrophage colony-stimulating factor (MCSF), MCSF receptor (MCSFR), and microRNA-122 (miR-122) in comparison to the traditional biomarker alanine aminotransferase (ALT). Biomarkers were evaluated individually and as a multivariate model in a cohort of acetaminophen overdose (n = 175) subjects and were further tested in cohorts of healthy adults (n = 135), patients with liver damage from various causes (n = 104), and patients with damage to the muscle (n = 74), kidney (n = 40), gastrointestinal tract (n = 37), and pancreas (n = 34). In the acetaminophen cohort, a multivariate model with GLDH, K18, and miR-122 was able to detect DILI more accurately than individual biomarkers alone. Furthermore, the three-biomarker model could accurately predict patients with liver injury compared with healthy volunteers or patients with damage to muscle, pancreas, gastrointestinal tract, and kidney. Expression of K18, GLDH, and miR-122 was evaluated using a database of transcriptomic profiles across multiple tissues/organs in humans and rats. K18 mRNA (Krt18) and MiR-122 were highly expressed in liver whereas GLDH mRNA (Glud1) was widely expressed. We performed a comprehensive, comparative performance assessment of 7 promising biomarkers and demonstrated that a 3-biomarker multivariate model can accurately detect liver injury.

    Other authors
    See publication
  • Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology

    EBioMedicine

    Adverse drug reactions (ADRs) are one of the leading causes of morbidity and mortality in health care. Understanding which drug targets are linked to ADRs can lead to the development of safer medicines. Here, we analyze in vitro secondary pharmacology of common (off) targets for 2134 marketed drugs. To associate these drugs with human ADRs, we utilized FDA Adverse Event Reports and developed random forest models that predict ADR occurrences from in vitro pharmacological profiles. By evaluating…

    Adverse drug reactions (ADRs) are one of the leading causes of morbidity and mortality in health care. Understanding which drug targets are linked to ADRs can lead to the development of safer medicines. Here, we analyze in vitro secondary pharmacology of common (off) targets for 2134 marketed drugs. To associate these drugs with human ADRs, we utilized FDA Adverse Event Reports and developed random forest models that predict ADR occurrences from in vitro pharmacological profiles. By evaluating Gini importance scores of model features, we identify 221 target-ADR associations, which co-occur in PubMed abstracts to a greater extent than expected by chance. Among these are established relations, such as the association of in vitro hERG binding with cardiac arrhythmias, which further validate our machine learning approach. Evidence on bile acid metabolism supports our identification of associations between the Bile Salt Export Pump and renal, thyroid, lipid metabolism, respiratory tract and central nervous system disorders. Unexpectedly, our model suggests PDE3 is associated with 40 ADRs. These associations provide a comprehensive resource to support drug development and human biology studies.

    Other authors
    See publication
  • Tissue-Specific Trans Regulation of the Mouse Epigenome

    Genetics

    The epigenetic landscape varies greatly among cell types. Although a variety of writers, readers, and erasers of epigenetic features are known, we have little information about the underlying regulatory systems controlling the establishment and maintenance of these features. Here, we have explored how natural genetic variation impacts the epigenome in mice. Studying levels of H3K4me3, a histone modification at sites such as promoters, enhancers, and recombination hotspots, we found…

    The epigenetic landscape varies greatly among cell types. Although a variety of writers, readers, and erasers of epigenetic features are known, we have little information about the underlying regulatory systems controlling the establishment and maintenance of these features. Here, we have explored how natural genetic variation impacts the epigenome in mice. Studying levels of H3K4me3, a histone modification at sites such as promoters, enhancers, and recombination hotspots, we found tissue-specific trans-regulation of H3K4me3 levels in four highly diverse cell types: male germ cells, embryonic stem (ES) cells, hepatocytes and cardiomyocytes. To identify the genetic loci involved, we measured H3K4me3 levels in male germ cells in a mapping population of 59 BXD recombinant inbred lines. We found extensive trans-regulation of H3K4me3 peaks, including six major histone quantitative trait loci (hQTL). These chromatin regulatory loci act dominantly to suppress H3K4me3, which at hotspots reduces the likelihood of subsequent DNA double-strand breaks. QTL locations do not correspond with genes encoding enzymes known to metabolize chromatin features. Instead their locations match clusters of zinc finger genes, making these possible candidates that explain the dominant suppression of H3K4me3. Collectively, these data describe an extensive, set of chromatin regulatory loci that control the epigenetic landscape.

    See publication
  • Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets

    BMC Systems Biology

    With the global emergence of multi-drug resistant strains of Mycobacterium tuberculosis, new strategies to treat tuberculosis are urgently needed such as therapeutics targeting potential human host factors.
    Here we performed a statistical meta-analysis of human gene expression in response to both latent and active pulmonary tuberculosis infections from nine published datasets. We found 1655 genes that were significantly differentially expressed during active tuberculosis infection. In…

    With the global emergence of multi-drug resistant strains of Mycobacterium tuberculosis, new strategies to treat tuberculosis are urgently needed such as therapeutics targeting potential human host factors.
    Here we performed a statistical meta-analysis of human gene expression in response to both latent and active pulmonary tuberculosis infections from nine published datasets. We found 1655 genes that were significantly differentially expressed during active tuberculosis infection. In contrast, no gene was significant for latent tuberculosis. Pathway enrichment analysis identified 90 significant canonical human pathways, including several pathways more commonly related to non-infectious diseases such as the LRRK2 pathway in Parkinson’s disease, and PD-1/PD-L1 signaling pathway important for new immuno-oncology therapies. The analysis of human genome-wide association studies datasets revealed tuberculosis-associated genetic variants proximal to several genes in major histocompatibility complex for antigen presentation. We propose several new targets and drug-repurposing opportunities including intravenous immunoglobulin, ion-channel blockers and cancer immuno-therapeutics for development as combination therapeutics with anti-mycobacterial agents.
    Our meta-analysis provides novel insights into host genes and pathways important for tuberculosis and brings forth potential drug repurposing opportunities for host-directed therapies.

    Other authors
    See publication
  • Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective

    PLoS Computational Biology

    Dysregulation of iron metabolism in cancer is well documented and it has been suggested that there is interdependence between excess iron and increased cancer incidence and progression. In an effort to better understand the linkages between iron metabolism and breast cancer, a predictive mathematical model of an expanded iron homeostasis pathway was constructed that includes species involved in iron utilization, oxidative stress response and oncogenic pathways. The model leads to three…

    Dysregulation of iron metabolism in cancer is well documented and it has been suggested that there is interdependence between excess iron and increased cancer incidence and progression. In an effort to better understand the linkages between iron metabolism and breast cancer, a predictive mathematical model of an expanded iron homeostasis pathway was constructed that includes species involved in iron utilization, oxidative stress response and oncogenic pathways. The model leads to three predictions. The first is that overexpression of iron regulatory protein 2 (IRP2) recapitulates many aspects of the alterations in free iron and iron-related proteins in cancer cells without affecting the oxidative stress response or the oncogenic pathways included in the model. This prediction was validated by experimentation. The second prediction is that iron-related proteins are dramatically affected by mitochondrial ferritin overexpression. This prediction was validated by results in the pertinent literature not used for model construction. The third prediction is that oncogenic Ras pathways contribute to altered iron homeostasis in cancer cells. This prediction was validated by a combination of simulation experiments of Ras overexpression and catalase knockout in conjunction with the literature. The model successfully captures key aspects of iron metabolism in breast cancer cells and provides a framework upon which more detailed models can be built.

    See publication
  • A Network Biology Approach to Denitrification in Pseudomonas aeruginosa

    PLOS ONE

    Pseudomonas aeruginosa is a metabolically flexible member of the Gammaproteobacteria. Under anaerobic conditions and the presence of nitrate, P. aeruginosa can perform (complete) denitrification, a respiratory process of dissimilatory nitrate reduction to nitrogen gas via nitrite (NO2), nitric oxide (NO) and nitrous oxide (N2O). This study focuses on understanding the influence of environmental conditions on bacterial denitrification performance, using a mathematical model of a metabolic…

    Pseudomonas aeruginosa is a metabolically flexible member of the Gammaproteobacteria. Under anaerobic conditions and the presence of nitrate, P. aeruginosa can perform (complete) denitrification, a respiratory process of dissimilatory nitrate reduction to nitrogen gas via nitrite (NO2), nitric oxide (NO) and nitrous oxide (N2O). This study focuses on understanding the influence of environmental conditions on bacterial denitrification performance, using a mathematical model of a metabolic network in P. aeruginosa. To our knowledge, this is the first mathematical model of denitrification for this bacterium. Analysis of the long-term behavior of the network under changing concentration levels of oxygen (O2), nitrate (NO3), and phosphate (PO4) suggests that PO4 concentration strongly affects denitrification performance. The model provides three predictions on denitrification activity of P. aeruginosa under various environmental conditions, and these predictions are either experimentally validated or supported by pertinent biological literature. One motivation for this study is to capture the effect of PO4 on a denitrification metabolic network of P. aeruginosa in order to shed light on mechanisms for greenhouse gas N2O accumulation during seasonal oxygen depletion in aquatic environments such as Lake Erie (Laurentian Great Lakes, USA). Simulating the microbial production of greenhouse gases in anaerobic aquatic systems such as Lake Erie allows a deeper understanding of the contributing environmental effects that will inform studies on, and remediation strategies for, other hypoxic sites worldwide.

    Other authors
    See publication
  • Microbiome Changes in Healthy Volunteers Treated with GSK1322322, a Novel Antibiotic Targeting Bacterial Peptide Deformylase

    Antimicrobial Agents and Chemotherapy

    GSK1322322 is a novel antibacterial agent under development, and it has known antibacterial activities against multidrug-resistant respiratory and skin pathogens through its inhibition of the bacterial peptide deformylase. Here, we used next-generation sequencing (NGS) of the bacterial 16S rRNA genes from stool samples collected from 61 healthy volunteers at the predosing and
    end-of-study time points to determine the effects of GSK1322322 on the gastrointestinal (GI) microbiota in a phase I,…

    GSK1322322 is a novel antibacterial agent under development, and it has known antibacterial activities against multidrug-resistant respiratory and skin pathogens through its inhibition of the bacterial peptide deformylase. Here, we used next-generation sequencing (NGS) of the bacterial 16S rRNA genes from stool samples collected from 61 healthy volunteers at the predosing and
    end-of-study time points to determine the effects of GSK1322322 on the gastrointestinal (GI) microbiota in a phase I, randomized, double-blind, and placebo-controlled study. GSK1322322 was administered either intravenously (i.v.) only or in an oral-i.v. combination in single- and repeat-dose-escalation infusions. Analysis of the 16S rRNA sequence data found no significant changes in the relative abundances of GI operational taxonomic units (OTUs) between the prestudy and end-of-study samples for either the placebo- or i.v.-only-treated subjects. However, oral-i.v. treatment resulted in significant decreases in some bacterial taxa, the Firmicutes and Bacteroidales, and increases in others, the Betaproteobacteria, Gammaproteobacteria, and Bifidobacteriaceae. Microbiome diversity plots clearly differentiated the end-of-study oral-i.v.-dosed samples from all others collected. The changes in genome function as inferred from species composition suggest an increase in bacterial transporter and xenobiotic metabolism pathways in these samples. A phylogenetic analysis of the peptide deformylase protein sequences collected from the published genomes of clinical isolates previously tested for GSK1322322 in vitro susceptibility and GI bacterial reference genomes suggests that antibiotic target homology is one of several factors that influences the response of GI microbiota to this antibiotic. Our study shows that dosing regimen and target class are important factors when considering the impact of antibiotic usage on GI microbiota.

    Other authors
  • Modeling Stochasticity and Variability in Gene Regulatory Networks

    EURASIP Journal on Bioinformatics and Systems Biology

    Modeling stochasticity in gene regulatory networks is an important and complex problem in molecular systems biology. To elucidate intrinsic noise, several modeling strategies such as the Gillespie algorithm have been used successfully. This study contributes an approach as an alternative to these classical settings. Within the discrete paradigm, where genes, proteins, and other molecular components of gene regulatory networks are modeled as discrete variables and are assigned as logical rules…

    Modeling stochasticity in gene regulatory networks is an important and complex problem in molecular systems biology. To elucidate intrinsic noise, several modeling strategies such as the Gillespie algorithm have been used successfully. This study contributes an approach as an alternative to these classical settings. Within the discrete paradigm, where genes, proteins, and other molecular components of gene regulatory networks are modeled as discrete variables and are assigned as logical rules describing their regulation through interactions with other components. Stochasticity is modeled at the biological function level under the assumption that even if the expression levels of the input nodes of an update rule guarantee activation or degradation there is a probability that the process will not occur due to stochastic effects. This approach allows a finer analysis of discrete models and provides a natural setup for cell population simulations to study cell-to-cell variability. We applied our methods to two of the most studied regulatory networks, the outcome of lambda phage infection of bacteria and the p53-mdm2 complex.

    Other authors
    See publication

Courses

  • Abstract Algebra

    -

  • Advanced Analysis

    -

  • Advanced Geometric Methods in Computer Science

    -

  • Applied Stochastic Processes

    -

  • Biological Paradigms for Bioinformatics

    -

  • Combinatorial Analysis and Graph Theory

    -

  • Combinatorics

    -

  • Communicating Science

    -

  • Complex Analysis

    -

  • Computation for Life Sciences

    -

  • Computational Cell Biology

    -

  • Digital System Organization and Design

    -

  • Independent Study

    -

  • Introduction to Computer Architecture

    -

  • Introduction to Systems Biology

    -

  • Mathematical Foundations of Computer Science

    -

  • Numerical Analysis

    -

  • Powerful Presentations for Proposals

    -

  • Programming Languages and Techniques

    -

  • Specialized Topics in Algebra

    -

  • Theory of Computation

    -

Projects

  • Modeling the Multiple Zinc Finger Protein PRDM9 Binding with Affinity-seq

    - Present

    Mammalian genomes contain over 700 zinc finger proteins (ZFPs), but most have unknown functions. One example, PR Domain Containing 9 (PRDM9), regulates location of meiotic homologous recombination by binding to the DNA, causing epigenetic modifications and allowing for a double strand break (DSB); however its targeting mechanism is not fully understood. Knockouts in mice PRDM9 have been associated with infertility, which is suspected to be caused by mislocation of DSBs during meiosis. Over 100…

    Mammalian genomes contain over 700 zinc finger proteins (ZFPs), but most have unknown functions. One example, PR Domain Containing 9 (PRDM9), regulates location of meiotic homologous recombination by binding to the DNA, causing epigenetic modifications and allowing for a double strand break (DSB); however its targeting mechanism is not fully understood. Knockouts in mice PRDM9 have been associated with infertility, which is suspected to be caused by mislocation of DSBs during meiosis. Over 100 alleles of PRDM9 are known in mice, each of which contains a unique zinc finger array and therefore selects different DNA binding sites for PRDM9. To detect and quantify all binding sites of PRDM9 without interference by additional regulatory effects (protein abundance, chromatin accessibility), we used a novel, in vitro assay called Affinity-Seq. We found over 39,000 significant binding sites for the PRDM9Dom2 allele in C57BL/6J mouse DNA. Quantification of the binding frequency at each sequence enabled estimation of binding affinity at each site in addition to standard nucleotide frequencies. To gauge the contribution of each nucleotide, we built a linear regression model that includes additive and interactive effects on the binding preference of PRDM9. We identified a few core nucleotides required for binding and additional bases that quantitatively modify binding affinity. We tested this model by performing Affinity-Seq on the CAST/EiJ genome providing various natural polymorphisms for quantitative validation. Our work yields a detailed view of the targeting mechanism of PRDM9 in meiosis and can be broadly applied to any ZFP.

    Other creators
  • A Regulatory Network of DNA Mismatch Repair

    -

    Although failure of DNA Mismatch Repair (MMR) is associated with microsatellite instability
    and colorectal cancer, little is known about MMR except for its biochemical pathway.
    By assembling known regulatory interactions, we built a novel gene regulatory network of MMR using a time- and state-discrete stochastic modeling framework. This model includes genes and microRNAs targeting MMR genes: MSH2, MSH6, MLH1, PMS2. We support the hypothesis that microRNAs can stabilize network dynamics…

    Although failure of DNA Mismatch Repair (MMR) is associated with microsatellite instability
    and colorectal cancer, little is known about MMR except for its biochemical pathway.
    By assembling known regulatory interactions, we built a novel gene regulatory network of MMR using a time- and state-discrete stochastic modeling framework. This model includes genes and microRNAs targeting MMR genes: MSH2, MSH6, MLH1, PMS2. We support the hypothesis that microRNAs can stabilize network dynamics, thus enhancing genomic stability, by showing that overexpressing microRNAs increases robustness while knocking them out seems to have the opposite effect. In
    addition to providing a gene regulatory network of MMR, the model yields various predictions and enables further analysis of the potential stabilizing effect of microRNAs on gene regulatory networks.

    Other creators

Languages

  • English

    Professional working proficiency

  • Turkish

    Native or bilingual proficiency

  • French

    Elementary proficiency

Organizations

  • New York Academy of Sciences

    -

    - Present
  • Healthcare Businesswomen’s Association

    -

    - Present
  • International Society for Computational Biology

    -

    - Present
  • Society for Advancement of Chicanos and Native Americans in Science

    -

    - Present
  • American Mathematical Society

    -

    - Present
  • Society for Industrial and Applied Mathematics

    -

    - Present
  • The Jackson Laboratory Postdoctoral Association (JPA)

    Co-chair

    -
  • Society for Mathematical Biology

    -

    -

View Seda’s full profile

  • See who you know in common
  • Get introduced
  • Contact Seda directly
Join to view full profile

People also viewed

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Seda Arat

Add new skills with these courses